The Current Ratio as of November 2024 (TTM) for Bionomics Limited (BNOX) is 3.30

According to Bionomics Limited’s latest financial reports and current stock price. The company's current Current Ratio is 3.30. This represents a change of -8.05% compared to the average of 3.59 of the last 4 quarters.

Bionomics Limited (BNOX) Historical Current Ratio (quarterly & annually)

How has BNOX Current Ratio performed in the past?

The mean historical Current Ratio of Bionomics Limited over the last ten years is 5.38. The current 3.30 Current Ratio has changed 6.04% with respect to the historical average. Over the past ten years (40 quarters), BNOX's Current Ratio was at its highest in in the December 2021 quarter at 13.46. The Current Ratio was at its lowest in in the December 2020 quarter at 0.74.

Bionomics Limited (BNOX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Bionomics Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Bionomics Limited (BNOX) Average Current Ratio

How has BNOX Current Ratio performed in the past?

The current Current Ratio of Bionomics Limited (BNOX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Bionomics Limited (BNOX) Current Ratio vs. Peers

How is BNOX’s Current Ratio compared to its peers?

Bionomics Limited’s Current Ratio is less than Accustem Sciences Inc. (0), greater than Hillstream BioPharma, Inc. (0.12), greater than Comera Life Sciences Holdings, Inc. (2.25), greater than SciSparc Ltd. (0.90), less than Anebulo Pharmaceuticals, Inc. (4.10), less than PMV Pharmaceuticals, Inc. (3.45), less than Miromatrix Medical Inc. (13.98), less than ZIVO Bioscience, Inc. (3.46), greater than Aerovate Therapeutics, Inc. (0.17), less than Adagene Inc. (8.78), greater than Acrivon Therapeutics, Inc. Common Stock (2.50), less than Rezolute, Inc. (12.75), less than AN2 Therapeutics, Inc. (13.79), less than null (9.75),

Build a custom stock screener for Bionomics Limited (BNOX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bionomics Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Bionomics Limited (BNOX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Bionomics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.